Recruiting now—Ages 18 Years and up
Multi-parametric Imaging in Personalized Radiotherapy
Sponsor: CNAO National Center of Oncological Hadrontherapy · NCT05888064 on ClinicalTrials.gov ↗
Conditions studied
Skull Base Chordoma
What it tests
- diffusion MRI sequencesdiagnostic_test
Where it's running1 site
1 international site
- Recruiting now
CNAO
Pavia, Pv, Italy 27100
- Cristina Bono, MSc(contact)0382078613[email protected]
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
Inclusion Criteria: * Patients with histologically confirmed diagnosis of chordoma of the skull base * Particle therapy with curative intent * Karnofsky Performance status greater than or equal to 60 * Patients with macroscopic disease detectable at pre-radiotherapy imaging * Patients undergoing PT with standardized treatment procedures * Patients who have signed the written informed consent for research Exclusion Criteria: * Metastatic disease * Palliative treatment * Other malignancies with disease-free interval \< 5 years (excepting pre- cancerous lesions) * Pregnancy * Simultaneous CHT or Immunotherapy * Extensive metal instrumentation/implants * Patients with autoimmune diseases (ADs) -including collagen-vascular (CVD) and inflammatory bowel (IBD)
Updated 2024-08-21 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.